Associations between cancer diagnosis and patients' responses to an inpatient tobacco treatment intervention
- PMID: 34197693
- PMCID: PMC8335828
- DOI: 10.1002/cam4.4082
Associations between cancer diagnosis and patients' responses to an inpatient tobacco treatment intervention
Abstract
Background: Diagnosis of a chronic illness, such as cancer may influence health behavior changes, such as smoking cessation. The present analyses examine associations between a cancer diagnosis (i.e., yes or no) and response to an opt-out smoking cessation bedside intervention provided to hospitalized patients. It was hypothesized that patients with a past or present cancer diagnosis would report higher motivation and engagement with quitting smoking, and higher rates of smoking abstinence after hospital discharge, compared to those without a cancer diagnosis.
Methods: Chart review was conducted on 5287 inpatients who accepted bedside treatment from a counselor and opted-in to automated follow-up calls from July 2014 to December 2019.
Results: At the time of inpatient assessment, those with a past or present cancer diagnosis (n = 419, 7.9%) endorsed significantly higher levels of importance of quitting than those without a cancer diagnosis (3.92/5 vs. 3.77/5), and were more likely to receive smoking cessation medication upon discharge (17.9% vs. 13.3%). Follow-up data from 30-days post-discharge showed those with a cancer diagnosis endorsed higher rates of self-reported abstinence (20.5%) than those without a cancer diagnosis (10.3%; p < 0.001).
Conclusion: Being hospitalized for any reason provides an opportunity for smokers to consider quitting. Having a previous diagnosis of cancer appears to increase intention to quit and lead to higher rates of smoking cessation in patients who are hospitalized compared to patients without cancer. Future research needs to work toward optimizing motivation for smoking cessation while admitted to a hospital and on improving quit rates for all admitted patients, regardless of diagnosis.
Keywords: cancer; cessation; hospitalization; inpatient; prevention; smoking; tobacco.
© 2021 The Authors. Cancer Medicine published by John Wiley & Sons Ltd.
Conflict of interest statement
B.A.T. and K.M.C. are consultants to Pfizer on an Advisory Board on e‐cigarettes and ways to improve smoking cessation delivery in health care settings. B.A.T. and K.M.C. testify on behalf of plaintiffs who have filed litigation against the tobacco industry.
Figures
References
-
- National Center for Chronic Disease Prevention and Health Promotion (US) Office on Smoking and Health . The health consequences of smoking—50 years of progress: A report of the surgeon general.Atlanta,GA: Centers for Disease Control and Prevention (US), 2014. PMID: 24455788. - PubMed
-
- Substance Abuse and Mental Health Services Administration, Office of the General Surgeon . Smoking Cessation: A Report of the Surgeon General. US Department of Health and Human Services; 2020.
-
- Warren GW, Simmons VN. Tobacco use and the cancer patient. In: Lawrence TL, ed. DeVita, Hellman, and Rosenberg's Cancer: Principles and Practice of Oncology. 11th ed. Lippincott, Williams, & Wilkins; 2019.
-
- Warren GW, Alberg AJ, Cummings KM, Dresler C. Smoking cessation after a cancer diagnosis is associated with improved survival. J Thorac Oncol. 2020;15(5):705‐708. - PubMed
-
- Shields PG, Herbst RS, Arenberg D, et al. Smoking cessation, version 1.2016, NCCN clinical practice guidelines. J Natl Compr Canc Netw. 2016;14(11):1430‐1468. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous